Sylvain Sachot
@jacobplieth.bsky.social
Journalist @ ApexOnco. The Wolverine Of Biotech / Mr ASH. Once had a blue tick. Interested in: oncology. Not interested in: what stock you bought today.
@profmakris.bsky.social
Emeritus Professor of Haemostasis and Thrombosis in Sheffield, UK. I tweet about thrombosis, hemophilia, COVID-19, medicine, NHS & AI. Opinions are my own.
@daphnezohar.bsky.social
Founder & CEO of www.SeaportTx.com developing new medicines for neuropsychiatric disorders. Co-founder Karuna Tx (KarXt/Cobenfy now at BMS). Founding CEO & Senior Advisor www.puretechhealth.com. Co founder/host @BiotechCH. Board of BIO #Biotech #BioSky
@endpts.com
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
@biopharmcatalyst.bsky.social
FDA catalyst calendar, newsletters, and more. We do not provide investment advice or recommendations. #biotech #stocks https://www.biopharmcatalyst.com/
@lifescivc.bsky.social
Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
@nicolewetsman.bsky.social
deputy editor @endpts.com // formerly the verge & abc news // soccer posts
@shelbylivingston.bsky.social
Reporter covering health tech for Endpoints News. Formerly Business Insider and Modern Healthcare. Charleston native, Clemson alum. Go Tigers!
@biotech.bsky.social
Biotech Investor | Finance / Biochemistry | Avid Runner | Bay Area / Asia
@crismarulandac.bsky.social
🔬 Analyst at BioPharmCatalyst | Passionate about #biotech & #economics | 🇨🇴 PEI ✈️ 🇺🇸 NYC | Enjoys ✈️📝⚽. No advice. Noticias #Biotecnología ES | LatAm🌎
@biotechhangout.bsky.social
@natbiotech.nature.com
Publishing the best of biotech science and business. Part of @natureportfolio.bsky.social. Find us on Twitter, Facebook & Instagram.
@biotechbro.bsky.social
@predatordiaries.com
Healthcare analyst after Principal in pricing & market access, healthcare fund manager, Scrip columnist & pharm PhD, MBA yada, yada. The other half of the http://smithandsheridan.eu podcast when we did it.
@mattokrebs.bsky.social
BioCentury Inc. ( www.biocentury.com ) * Empowering Biopharma & Finance Execs | Travel Junkie & weekend warrior golfer * Global Strategic Account Manager & Growth Team Sales Manager
@augustonyc.bsky.social
Hepatologist focused on liver cancer. Medical Director, Liver Cancer Program at NYU Langone. Tweets are mine. Like/retweet ≠ endorsement
@biorxiv-immuno.bsky.social
@richardsever.bsky.social
Co-Founder, bioRxiv and medRxiv. Assistant Director, Cold Spring Harbor Laboratory Press.
@biorxiv-synthbio.bsky.social
@biorxiv-molbio.bsky.social
@robertcoffin.bsky.social
Ex-academic (many years ago) & biotech entrepreneur, including at Biovex & $REPL inc
@applehelix.bsky.social
Entrepreneur. Drug hunter. Novice biotech scripophile. Anti-ideologues. Proudly blocked by Vinay Prasad. http://linkedin.com/in/jliang1/
@synbio1.bsky.social
Synthetic Biologist - Foundry Theorist foundrytheory.substack.com stay humble biodesigners
@franksdavid.bsky.social
Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
@crick.ac.uk
We're the Crick, a biomedical research lab in London working to figure out how life works. Home to more than 2,000 scientists and a free public exhibition space. https://www.crick.ac.uk/
@antonioregalado.bsky.social
Journalist covering biotechnology for MIT Technology Review. Scoops about new methods in genetics and cell biology. The "playing God" beat. Gene editing, gene therapy, ancient DNA, synthetic embryos, cloning, etc.
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. [email protected] and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@simonbayly.bsky.social
Reformed chemist 👨🔬 IP licensing and spinouts at the Francis Crick Institute. Also post about cycling 🚲 Opinion my own etc.
@katiepalmer.bsky.social
Health tech correspondent at STAT News (www.statnews.com) Share tips: [email protected] Signal: palmer.01
@downing.bsky.social
Co-founder of The Light Collective www.lightcollective.org Security Researcher Health Infosec Views are my own.
@lisamjarvis.bsky.social
Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
@scottgottliebmd.bsky.social
Senior Fellow at the American Enterprise Institute. Partner, New Enterprise Associates. Contributor CNBC. 23rd Commissioner of the U.S. FDA. Public boards: Pfizer, Illumina, TempusAI.
@dshaywitz.bsky.social
Rangy MD/PhD executive applying AI & digital technologies to biopharma & healthy aging. Player-coach. #Biosky #Medsky Also Timmerman Report, DBMI@HMS, AEI; https://www.astoundinghealthtech.com/
@shafferbiotech.bsky.social
Biotech entrepreneur and consultant. Biochem PhD. Opinions strictly my own.
@dbsable.bsky.social
Doctor/teacher/writer. Ob/gyn and IVF doc. Roadie for Priya Mayadas. Adjunct @Columbia https://dbsable.substack.com
@biotechtv.bsky.social
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
@elaineywchen.bsky.social
Reporter @statnews.com covering drugs and the biopharma industry | signal: elaineywchen.70
@rickberke.bsky.social
Co-founder & Executive Editor, STAT (www.statnews.com) @statnews.bsky.social Longtime reporter/editor NYT
@pauljaschke.bsky.social
Senior Lecturer in Synthetic Biology, Macquarie University | Engineering phage & microbes to discover and create new biology.🇨🇦🇦🇺 👨👩👦👦 🦠🧬